Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Merck
Moodys
Boehringer Ingelheim
Dow

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Phentermine hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for phentermine hydrochloride and what is the scope of patent protection?

Phentermine hydrochloride is the generic ingredient in eleven branded drugs marketed by Teva, Glaxosmithkline, Ferndale Labs, Shire Richwood, Mast Mm, Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Kvk Tech, Lannett, Lannett Co Inc, Nuvo Pharm, Sandoz, Sun Pharm Industries, Tg United Inc, Upsher Smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms, Citius Pharms, Avanthi Inc, Actavis Elizabeth, Kvk Tech Inc, Novast Labs, Polygen Pharms, Prinston Inc, Sandoz Inc, Sun Pharm Inds Inc, Solvay, and Vivus, and is included in one hundred NDAs. There are eleven patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Phentermine hydrochloride has two patent family members in two countries.

There are seventeen drug master file entries for phentermine hydrochloride. Thirty-six suppliers are listed for this compound.

Recent Clinical Trials for phentermine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado- Nutrition Obesity Research CenterPhase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
Jaime Moore, MD MPHPhase 2

See all phentermine hydrochloride clinical trials

Recent Litigation for phentermine hydrochloride

Identify potential future generic entrants

District Court Litigation
Case NameDate
ALPEX PHARMA, S.A. v. ZYDUS PHARMACEUTICALS USA, INC.2013-07-01

See all phentermine hydrochloride litigation

PTAB Litigation
PetitionerDate
Erich, Spangenberg2015-11-24

See all phentermine hydrochloride litigation

Pharmacology for phentermine hydrochloride
Synonyms for phentermine hydrochloride
.alpha.-Methylamphetamine hydrochloride
.alpha.,.alpha.-Dimethylphenethylamine hydrochloride
(1,1-DIMETHYL-2-PHENYL)ETHYLAMINE HYDROCHLORIDE
0K2I505OTV
1-Phenyl-2-methyl-2-aminopropane hydrochloride
1-phenyl-2-methyl-2-aminopropanehydrochloride
1-Phenyl-2-methyl-2-propylamine Hydrochloride
1,1-Dimethyl-2-phenylethylamine hydrochloride
1197-21-3
122-09-8 (Parent)
2-Amino-2-methyl-1-phenylpropane hydrochloride
2-methyl-1-phenyl-2-propanamine hydrochloride
2-Methyl-1-phenylpropan-2-amine hydrochloride
2-methyl-1-phenylpropan-2-amine;hydrochloride
AC1L2F9M
Adipex-P
Adipex-p (TN)
AKOS015891196
alpha-Methylamphetamine hydrochloride
alpha-methylamphetaminehydrochloride
alpha,alpha-dimethyl-phenethylaminhydrochloride
alpha,alpha-Dimethylphenethylamine hydrochloride
ANW-58508
AOB5784
API0007710
AS01627
BCP23776
Benzeneethanamine, alpha,alpha-dimethyl-, hydrochloride
Benzeneethanamine, alpha,alpha-dimethyl, hydrochloride
Benzeneethanamine,.alpha.-dimethyl, hydrochloride
benzeneethanamine,alpha,alpha-dimethyl,hydrochloride
CCG-221139
CHEBI:50506
CHEMBL1200912
CTK6A7128
D05459
DEA No. 1640
DTXSID20152550
Duromine Hydrochloride
EINECS 214-821-9
Fastin
Fastin (TN)
FT-0673716
I01-8880
I14-44888
Inoamin Hydrochloride
Ionamin Hydrochloride
Linyl Hydrochloride
Lipopill Hydrochloride
Lomaira
Lonamin Hydrochloride
LS-103359
MG 18370
MG 18570
Mirapront Hydrochloride
MLS003882563
NCAIGTHBQTXTLR-UHFFFAOYSA-N
Normephentermine Hydrochloride
NSC 44090
NSC-44090
NSC44090
Obestin-30
Oby-Trim
Omnibex Hydrochloride
Ona Mast
Ona-Mast
Ona-Mast hydrochloride
Phenethylamine, alpha,alpha-dimethyl-, hydrochloride
Phenteral
Phenteramine hydrochloride
Phentermine HCl
Phentermine hydrochloride (USP)
Phentermine hydrochloride [USAN]
Phentermine hydrochloride [USP]
Phentermine hydrochloride, >=98% (HPLC)
Phentermine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Phentermyl Wyncaps
Phenyl-t-butylamine hydrochloride
phenyl-t-butylaminehydrochloride
Phenyl-tert-butylamine Hydrochloride
S 58
SCHEMBL41585
SMR000058739
Suprenza
TC-147253
TL8000587
Tora
UNII-0K2I505OTV
Wilpo (VAN)
Wilpo Hydrochloride
wilpohydrochloride
WLN: ZX1&1&1R &GH
Paragraph IV (Patent) Challenges for PHENTERMINE HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
SUPRENZA TABLET, ORALLY DISINTEGRATING;ORAL phentermine hydrochloride 202088 2013-03-22
SUPRENZA TABLET, ORALLY DISINTEGRATING;ORAL phentermine hydrochloride 202088 2012-10-19

US Patents and Regulatory Information for phentermine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088625-001 Aug 23, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Vivus QSYMIA phentermine hydrochloride; topiramate CAPSULE, EXTENDED RELEASE;ORAL 022580-002 Jul 17, 2012 RX Yes No   Start Trial   Start Trial   Start Trial
Invagen Pharms PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 202858-002 Feb 14, 2014 AA RX No No   Start Trial   Start Trial   Start Trial
Teva PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 086911-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mast Mm ONA-MAST phentermine hydrochloride CAPSULE;ORAL 086516-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 203068-001 Aug 6, 2014 AA RX No No   Start Trial   Start Trial   Start Trial
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 087805-001 Dec 6, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for phentermine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-001 Jun 13, 2011   Start Trial   Start Trial
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-003 Mar 27, 2012   Start Trial   Start Trial
Citius Pharms SUPRENZA phentermine hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 202088-002 Jun 13, 2011   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Express Scripts
AstraZeneca
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.